UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 83

Sortiert nach

Nanoparticle albumin-bound paclitaxel for second-line treatment of metastatic urothelial carcinoma: a single group, multicentre, phase 2 study

The lancet oncology, 2013-07, Vol.14 (8), p.769-776

2013

Volltextzugriff (PDF)

Phase II Trial of Sorafenib in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or Nasopharyngeal Carcinoma

Journal of clinical oncology, 2007-08, Vol.25 (24), p.3766-3773

2007

Volltextzugriff (PDF)

Great expectations: patients’ preferences for clinically significant results from genomic sequencing

Human genetics, 2023-04, Vol.142 (4), p.553-562

2023

Volltextzugriff (PDF)

Towards a Postgraduate Oncology Training Model for Family Medicine: Mixed Methods Evaluation of a Breast Oncology Rotation

Current oncology (Toronto), 2022-09, Vol.29 (9), p.6485-6495

2022

Volltextzugriff (PDF)

Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancer

Breast cancer research and treatment, 2018-02, Vol.168 (1), p.159-168

2018

Volltextzugriff (PDF)

Oncology education for family medicine residents: a national needs assessment survey

BMC medical education, 2020-08, Vol.20 (1), p.283-9, Article 283

2020

Volltextzugriff (PDF)

Breast Cancer Mortality among Women with a BRCA1 or BRCA2 Mutation in a Magnetic Resonance Imaging Plus Mammography Screening Program

Cancers, 2020-11, Vol.12 (11), p.3479

2020

Volltextzugriff (PDF)

P538: Curious but cautious: Patients’ preferences for all types of clinically actionable genomic incidental results

Genetics in Medicine Open, 2024, Vol.2, p.101437, Article 101437

2024

Volltextzugriff (PDF)

P523: Returning all clinically relevant findings from genomic sequencing: Preliminary results from the incidental genomics RCT

Genetics in Medicine Open, 2024, Vol.2, p.101422, Article 101422

2024

Volltextzugriff (PDF)

P555: Clinical utility returning of all types of medically relevant genomic sequencing findings: An observational study

Genetics in Medicine Open, 2024, Vol.2, p.101454, Article 101454

2024

Volltextzugriff (PDF)

Additional germline findings from a tumor profiling program

BMC medical genomics, 2018-08, Vol.11 (1), p.65-65, Article 65

2018

Volltextzugriff (PDF)

P409: Clinical utility of genomic sequencing for hereditary cancer syndromes: An observational chart review

Genetics in Medicine Open, 2023, Vol.1 (1), p.100445, Article 100445

2023

Volltextzugriff (PDF)

Immune Checkpoint Inhibitor Exposure in Pregnancy: A Scoping Review

Journal of immunotherapy (1997), 2022-06, Vol.45 (5), p.231

2022

Volltextzugriff (PDF)

Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation

Breast cancer research and treatment, 2023-09, Vol.201 (2), p.257-264

2023

Volltextzugriff (PDF)

Blood levels of vitamin D and early stage breast cancer prognosis: a systematic review and meta-analysis

Breast cancer research and treatment, 2013-10, Vol.141 (3), p.331-339

2013

Volltextzugriff (PDF)

Widening the lens of actionability: A qualitative study of primary care providers' views and experiences of managing secondary genomic findings

European journal of human genetics : EJHG, 2022-05, Vol.30 (5), p.595-603

2022

Volltextzugriff (PDF)

Effectiveness of the Genomics ADvISER decision aid for the selection of secondary findings from genomic sequencing: a randomized clinical trial

Genetics in medicine, 2020-04, Vol.22 (4), p.727-735

2020

Volltextzugriff (PDF)

Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation

Gynecologic oncology, 2022-03, Vol.164 (3), p.514-521

2022

Volltextzugriff (PDF)

Abstract 601: Cognitive sequelae of adjuvant endocrine therapy in older women treated for early-stage breast cancer

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.601-601

2018

Volltextzugriff (PDF)

The risks of breast and ovarian cancer associated with the Ashkenazi Jewish founder allele BRCA2 6174delT

Clinical genetics, 2022-03, Vol.101 (3), p.317-323

2022

Volltextzugriff (PDF)

The risks of cancer in older women with BRCA pathogenic variants: How far have we come?

Cancer, 2023-03, Vol.129 (6), p.901-907

2023

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(76)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Nanoparticle albumin-bound paclitaxel for second-line treatment of metastatic urothelial carcinoma: a single group, multicentre, phase 2 study

Phase II Trial of Sorafenib in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or Nasopharyngeal Carcinoma

Great expectations: patients’ preferences for clinically significant results from genomic sequencing

Towards a Postgraduate Oncology Training Model for Family Medicine: Mixed Methods Evaluation of a Breast Oncology Rotation

Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial

Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancer

Genetics Adviser: a protocol for a mixed-methods randomised controlled trial evaluating a digital platform for genetics service delivery

Oncology education for family medicine residents: a national needs assessment survey

Breast Cancer Mortality among Women with a BRCA1 or BRCA2 Mutation in a Magnetic Resonance Imaging Plus Mammography Screening Program

P538: Curious but cautious: Patients’ preferences for all types of clinically actionable genomic incidental results

P523: Returning all clinically relevant findings from genomic sequencing: Preliminary results from the incidental genomics RCT

P555: Clinical utility returning of all types of medically relevant genomic sequencing findings: An observational study

Additional germline findings from a tumor profiling program

P409: Clinical utility of genomic sequencing for hereditary cancer syndromes: An observational chart review

Immune Checkpoint Inhibitor Exposure in Pregnancy: A Scoping Review

Impact of Geriatric Assessment and Management on Quality of Life, Unplanned Hospitalizations, Toxicity, and Survival for Older Adults With Cancer: The Randomized 5C Trial

Remote, proactive, telephone based management of toxicity in outpatients during adjuvant or neoadjuvant chemotherapy for early stage breast cancer: pragmatic, cluster randomised trial

Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation

Blood levels of vitamin D and early stage breast cancer prognosis: a systematic review and meta-analysis

Widening the lens of actionability: A qualitative study of primary care providers' views and experiences of managing secondary genomic findings

Effectiveness of the Genomics ADvISER decision aid for the selection of secondary findings from genomic sequencing: a randomized clinical trial

Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation

Abstract 601: Cognitive sequelae of adjuvant endocrine therapy in older women treated for early-stage breast cancer

The risks of breast and ovarian cancer associated with the Ashkenazi Jewish founder allele BRCA2 6174delT

The risks of cancer in older women with BRCA pathogenic variants: How far have we come?

Suchergebnisse filtern